Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Ingre

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Lakartidningen|March 11, 2020
[Quality of life the goal of care for patients with ALS]Caroline Ingre, Ingela Nygren, Anne Zachau, et al.
Journal of Neurology|February 22, 2024
Increased incidence of motor neuron disease in Sweden: a population-based study during 2002-2021Sofia Imrell, Fang Fang, Caroline Ingre, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 12, 2025
Minimum clinically important difference for drug effectiveness in an area of patient-oriented therapeutic goals in amyotrophic lateral sclerosisAdriano Chiò, Juliette Foucher, Kelly G Gwathmey, et al.
Nature Reviews. Neurology|November 10, 2023
Biomarkers in amyotrophic lateral sclerosis: current status and future prospectsRoisin McMackin, Peter Bede, Caroline Ingre, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 23, 2021
Mortality among family members of patients with amyotrophic lateral sclerosis - a Swedish register-based studyUlf Kläppe, Elisa Longinetti, Henrik Larsson, et al.
Systematic Reviews|April 23, 2024
The usage of population and disease registries as pre-screening tools for clinical trials, a systematic reviewJuliette Foucher, Louisa Azizi, Linn Öijerstedt, et al.
Clinical Epidemiology|February 25, 2015
Risk factors for amyotrophic lateral sclerosisCaroline Ingre, Per M Roos, Fredrik Piehl, et al.
BMC Medicine|August 4, 2022
Medication use and risk of amyotrophic lateral sclerosis-a systematic reviewCan Cui, Jiangwei Sun, Kyla A McKay, et al.
Neurology|March 30, 2020
Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosisCaroline Ingre, Lin Chen, Yiqiang Zhan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 31, 2026
Methodological considerations in the analysis of survival data in amyotrophic lateral sclerosisSolmaz Yazdani, Christina Seitz, John Andersson, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Lakartidningen|March 11, 2020
[Quality of life the goal of care for patients with ALS]Caroline Ingre, Ingela Nygren, Anne Zachau, et al.
Journal of Neurology|February 22, 2024
Increased incidence of motor neuron disease in Sweden: a population-based study during 2002-2021Sofia Imrell, Fang Fang, Caroline Ingre, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 12, 2025
Minimum clinically important difference for drug effectiveness in an area of patient-oriented therapeutic goals in amyotrophic lateral sclerosisAdriano Chiò, Juliette Foucher, Kelly G Gwathmey, et al.
Nature Reviews. Neurology|November 10, 2023
Biomarkers in amyotrophic lateral sclerosis: current status and future prospectsRoisin McMackin, Peter Bede, Caroline Ingre, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 23, 2021
Mortality among family members of patients with amyotrophic lateral sclerosis - a Swedish register-based studyUlf Kläppe, Elisa Longinetti, Henrik Larsson, et al.
Systematic Reviews|April 23, 2024
The usage of population and disease registries as pre-screening tools for clinical trials, a systematic reviewJuliette Foucher, Louisa Azizi, Linn Öijerstedt, et al.
Clinical Epidemiology|February 25, 2015
Risk factors for amyotrophic lateral sclerosisCaroline Ingre, Per M Roos, Fredrik Piehl, et al.
BMC Medicine|August 4, 2022
Medication use and risk of amyotrophic lateral sclerosis-a systematic reviewCan Cui, Jiangwei Sun, Kyla A McKay, et al.
Neurology|March 30, 2020
Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosisCaroline Ingre, Lin Chen, Yiqiang Zhan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 31, 2026
Methodological considerations in the analysis of survival data in amyotrophic lateral sclerosisSolmaz Yazdani, Christina Seitz, John Andersson, et al.
Pageof 9